1,1-Bis(3'-indolyl)-1-(p-bromophenyl)methane and related compounds repress survivin and decrease gamma-radiation-induced survivin in colon and pancreatic cancer cells
- PMID: 19787275
- PMCID: PMC2844344
- DOI: 10.3892/ijo_00000436
1,1-Bis(3'-indolyl)-1-(p-bromophenyl)methane and related compounds repress survivin and decrease gamma-radiation-induced survivin in colon and pancreatic cancer cells
Abstract
1,1-Bis(3'-indolyl)-1-(p-bromophenyl)methane (DIM-C-pPhBr) and the 2,2'-dimethyl analog (2,2'-diMeDIM-C-pPhBr) inhibit proliferation and induce apoptosis in SW480 colon and Panc28 pancreatic cancer cells. In this study, treatment with 10-20 microM concentrations of these compounds for 24 h induced cleaved PARP and decreased survivin protein and mRNA expression in both cell lines. However, results of time course studies show that DIM-C-pPhBr and 2,2'-diMeDIM-C-pPhBr decrease survivin protein within 2 h after treatment, whereas survivin mRNA levels were decreased only at later time-points indicating activation of transcription-independent and -dependent pathways for downregulation of survivin. In addition, we also observed that gamma-radiation inhibited pancreatic and colon cancer cell growth and this was associated with enhanced expression of survivin after 24 (SW480) or 24 and 48 h (Panc28) and correlated with previous studies on the role of survivin in radiation-resistance. However, in cells co-treated with gamma-radiation plus DIM-C-pPhBr or 2,2'-diMeDIM-C-pPhBr, induction of survivin by gamma-radiation was inhibited after co-treatment with both compounds, suggesting applications for these drugs in combination cancer chemotherapy with gamma-radiation.
Figures







Similar articles
-
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.Carcinogenesis. 2008 Jun;29(6):1139-47. doi: 10.1093/carcin/bgn103. Epub 2008 May 5. Carcinogenesis. 2008. PMID: 18460448 Free PMC article.
-
Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3'-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells.Biochem Pharmacol. 2012 May 15;83(10):1445-55. doi: 10.1016/j.bcp.2012.02.021. Epub 2012 Mar 3. Biochem Pharmacol. 2012. PMID: 22405837 Free PMC article.
-
Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.Cancer Res. 2010 Sep 1;70(17):6824-36. doi: 10.1158/0008-5472.CAN-10-1992. Epub 2010 Jul 21. Cancer Res. 2010. PMID: 20660371 Free PMC article.
-
[Influence of survivin gene repression by RNA interference on the radiosensitivity and chemosensitivity to cisplatin of cervical cancer cell HeLa].Zhonghua Fu Chan Ke Za Zhi. 2006 Aug;41(8):554-8. Zhonghua Fu Chan Ke Za Zhi. 2006. PMID: 17083843 Chinese.
-
Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3'-indoly)-1-(p-substituted phenyl)methanes.Mol Cancer Ther. 2008 Oct;7(10):3363-72. doi: 10.1158/1535-7163.MCT-08-0439. Mol Cancer Ther. 2008. PMID: 18852139 Free PMC article.
Cited by
-
Molecular targets for radiation oncology in prostate cancer.Front Oncol. 2011 Jul 13;1:17. doi: 10.3389/fonc.2011.00017. eCollection 2011. Front Oncol. 2011. PMID: 22645712 Free PMC article.
-
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.Anticancer Res. 2011 Nov;31(11):3799-807. Anticancer Res. 2011. PMID: 22110202 Free PMC article.
-
Mechanisms and therapeutic implications of cell death induction by indole compounds.Cancers (Basel). 2011 Jul 19;3(3):2955-74. doi: 10.3390/cancers3032955. Cancers (Basel). 2011. PMID: 24212940 Free PMC article.
-
Expression of the antiapoptotic protein survivin in colon cancer.Clin Colorectal Cancer. 2011 Sep;10(3):188-93. doi: 10.1016/j.clcc.2011.03.014. Epub 2011 Apr 28. Clin Colorectal Cancer. 2011. PMID: 21855041 Free PMC article.
References
-
- Altieri DC. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol. 2006;18:609–615. - PubMed
-
- Deveraux QL, Reed JC. IAP family proteins--suppressors of apoptosis. Genes Dev. 1999;13:239–252. - PubMed
-
- Stauber RH, Mann W, Knauer SK. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res. 2007;67:5999–6002. - PubMed
-
- Lens SM, Vader G, Medema RH. The case for Survivin as mitotic regulator. Curr Opin Cell Biol. 2006;18:616–622. - PubMed
-
- Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis. 2007;28:1133–1139. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous